IP41-27: Evaluation of the MODAPLEX multiplex mRNA assay in muscle-invasive bladder cancer: comparison of responders and non-responders after neoadjuvant gemcitabine/cisplatin therapy

IP41-27: Evaluation of the MODAPLEX multiplex mRNA assay in muscle-invasive bladder cancer: comparison of responders and non-responders after neoadjuvant gemcitabine/cisplatin therapy

Saturday, May 16, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)
147A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!